MGMT and central nervous system cancer: Molecular markers of DNA methylation for the early diagnosis and prognosis prediction of tumors and tumor-targeting drugs based on epigenetics have been widely studied, for example, the application of O-6-methylguanine-DNA methyltransferase (MGMT) DNA methylation in molecular diagnosis of glioma (14–16).